4 Results for "

NCI H23

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "NCI H23" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-132295
CAS No.: 2376146-48-2
Purity:  99.96%
Synonyms: ZN-c3
Target:  

Wee1

Research Areas:  

Cancer

Azenosertib (ZN-c3) is a selective, orally active inhibitor for Wee1 inhibitor (IC50=3.9 nM). Azenosertib exhibits antitumor activity .
loading...
    loading...
Cat. No.: HY-179403
CAS No.: 2966924-23-0
Target:  

Ras

Research Areas:  

Cancer

KRASG12C IN-17 is an orally active covalent KRAS G12C inhibitor, showing strong inhibitory activity in KRAS G12C-mutant cancer cells (NCI-H23 IC50 = 0.7 nM; NCI-H358 IC50 = 0.5 nM). KRASG12C IN-17 covalently and irreversibly binds to KRAS G12C with > 96% modification efficiency in both GDP-bound and GMPPNP-bound conformations. KRASG12C IN-17 can be used for studies of KRAS-driven cancers, including colorectal cancer .
loading...
    loading...
Cat. No.: HY-170995
Target:  

PROTACs ROR Apoptosis

Research Areas:  

Cancer

PROTAC ROR1 degrader-1 is a ROR1 PROTAC degrader with DC50 values of 40.88 nM (NCI-H23), 69.0 nM (NCI-H460), 83.35 nM (NCI-H1299) and 42.07 nM (NCI-H1975), respectively. PROTAC ROR1 degrader-1 inhibits the proliferation of lung cancer cells and induces apoptosis. PROTAC ROR1 degrader-1 can be used in research related to non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-170508
CAS No.: 3060588-16-8
Target:  

Cytochrome P450

Research Areas:  

Endocrinology

Aromatase-IN-4 (Compound 6a) is an aromatase (Aromatase) inhibitor. Aromatase-IN-4 exhibits anticancer activity, with GI50 values of 2.95 μM, 3.35 μM, 2.27 μM, 8.46 nM, and 1.56 μM against the MDAMB-231, MCF-7, A-549, NCI-H23, and A-498 cell lines, respectively . Aromatase-IN-4 effectively blocks aromatase-dependent estrogen production .
loading...
    loading...